CNTA: Centessa Pharmaceuticals Plc Financial Statements
Balance sheet, income statement, and cash flow statements for Centessa Pharmaceuticals Plc (CNTA).
$2.21B Market Cap.
CNTA Market Cap. (MRY)
CNTA Shares Outstanding (MRY)
CNTA Assets (MRY)
Total Assets
$576.80M
Total Liabilities
$175.25M
Total Investments
$98.96M
CNTA Income (MRY)
Revenue
$0
Net Income
-$235.76M
Operating Expense
$201.06M
CNTA Cash Flow (MRY)
CF Operations
-$142.06M
CF Investing
$31.27M
CF Financing
$364.75M
CNTA Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $576,798,000 (60.11%) | $360,246,000 (-18.92%) | $444,307,000 (-29.43%) | $629,635,000 (5273.69%) |
Assets Current | $536,409,000 (70.24%) | $315,092,000 (-28.02%) | $437,747,000 (-30.38%) | $628,774,000 (5531.65%) |
Assets Non-Current | $40,389,000 (-10.55%) | $45,154,000 (588.32%) | $6,560,000 (661.90%) | $861,000 (55.98%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $401,545,000 (69.97%) | $236,244,000 (-29.72%) | $336,169,000 (-31.61%) | $491,554,000 (15766.82%) |
Property Plant & Equipment Net | $11,757,000 (-9.23%) | $12,953,000 (1008.99%) | $1,168,000 (620.99%) | $162,000 (0%) |
Cash & Equivalents | $383,221,000 (199.32%) | $128,030,000 (-67.48%) | $393,644,000 (-33.85%) | $595,082,000 (8134.15%) |
Accumulated Other Comprehensive Income | $4,213,000 (182.18%) | $1,493,000 (199.73%) | -$1,497,000 (-317.59%) | $688,000 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $98,956,000 (-23.00%) | $128,519,000 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $98,956,000 (-23.00%) | $128,519,000 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $7,143,000 (-39.54%) | $11,815,000 (-14.61%) | $13,836,000 (71.56%) | $8,065,000 (681.49%) |
Accumulated Retained Earnings (Deficit) | -$988,702,000 (-31.31%) | -$752,945,000 (-25.10%) | -$601,860,000 (-56.06%) | -$385,653,000 (-1619.90%) |
Tax Assets | $70,354,000 (4.28%) | $67,465,000 (143.75%) | $27,678,000 (79.82%) | $15,392,000 (383.27%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $117,226,000 (38.58%) | $84,588,000 (21.19%) | $69,800,000 (-7.79%) | $75,700,000 (1245.30%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $117,226,000 (38.58%) | $84,588,000 (21.19%) | $69,800,000 (-7.79%) | $75,700,000 (0%) |
Total Liabilities | $175,253,000 (41.33%) | $124,002,000 (14.67%) | $108,138,000 (-21.69%) | $138,081,000 (1502.05%) |
Liabilities Current | $57,998,000 (47.26%) | $39,385,000 (2.73%) | $38,338,000 (55.61%) | $24,638,000 (185.86%) |
Liabilities Non-Current | $117,255,000 (38.57%) | $84,617,000 (21.23%) | $69,800,000 (-38.47%) | $113,443,000 (0%) |
CNTA Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $6,853,000 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $50,811,000 (-5.43%) | $53,731,000 (-2.66%) | $55,200,000 (28.71%) | $42,888,000 (3665.41%) |
Research & Development Expense | $150,244,000 (20.77%) | $124,405,000 (-19.78%) | $155,083,000 (62.12%) | $95,660,000 (928.49%) |
Operating Expenses | $201,055,000 (12.87%) | $178,136,000 (-15.14%) | $209,921,000 (-44.53%) | $378,454,000 (3525.04%) |
Interest Expense | $10,090,000 (1.86%) | $9,906,000 (36.13%) | $7,277,000 (520.90%) | $1,172,000 (1623.53%) |
Income Tax Expense | $2,844,000 (111.35%) | -$25,056,000 (-3254.22%) | -$747,000 (-755.26%) | $114,000 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$235,757,000 (-56.04%) | -$151,085,000 (30.12%) | -$216,207,000 (43.26%) | -$381,071,000 (-3473.77%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$235,757,000 (-56.04%) | -$151,085,000 (30.12%) | -$216,207,000 (43.26%) | -$381,071,000 (-3473.77%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$235,757,000 (-56.04%) | -$151,085,000 (30.12%) | -$216,207,000 (43.26%) | -$381,071,000 (-3473.77%) |
Weighted Average Shares | $114,473,449 (19.02%) | $96,177,578 (2.97%) | $93,400,513 (24.26%) | $75,166,456 (-12.52%) |
Weighted Average Shares Diluted | $114,473,449 (19.02%) | $96,177,578 (2.97%) | $93,400,513 (24.26%) | $75,166,456 |
Earning Before Interest & Taxes (EBIT) | -$222,823,000 (-34.04%) | -$166,235,000 (20.72%) | -$209,677,000 (44.79%) | -$379,785,000 (-3484.57%) |
Gross Profit | $0 (0%) | $6,853,000 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$201,055,000 (-17.38%) | -$171,283,000 (18.41%) | -$209,921,000 (44.53%) | -$378,454,000 (-3525.04%) |
CNTA Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $31,267,000 (124.62%) | -$127,004,000 (-13541.68%) | -$931,000 (-101.47%) | $63,256,000 (0%) |
Net Cash Flow from Financing | $364,752,000 (1627.29%) | $21,117,000 (4520.79%) | $457,000 (-99.93%) | $660,147,000 (48368.94%) |
Net Cash Flow from Operations | -$142,055,000 (11.40%) | -$160,342,000 (20.05%) | -$200,546,000 (-48.43%) | -$135,109,000 (-1171.02%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $255,191,000 (196.08%) | -$265,614,000 (-31.86%) | -$201,438,000 (-134.14%) | $590,116,000 (6416.13%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $63,442,000 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $31,301,000 (124.68%) | -$126,835,000 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$34,000 (79.88%) | -$169,000 (85.14%) | -$1,137,000 (-511.29%) | -$186,000 (0%) |
Issuance (Repayment) of Debt Securities | -$762,000 (0%) | $0 (0%) | $0 (0%) | $73,930,000 (5332.04%) |
Issuance (Purchase) of Equity Shares | $370,832,000 (1656.08%) | $21,117,000 (2841.09%) | $718,000 (-99.79%) | $344,915,000 (34491400.00%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $1,227,000 (99.51%) | $615,000 (247.13%) | -$418,000 (-122.94%) | $1,822,000 (2529.33%) |
Share Based Compensation | $33,546,000 (14.13%) | $29,392,000 (17.73%) | $24,965,000 (68.10%) | $14,851,000 (4319.94%) |
Depreciation Amortization & Accretion | $942,000 (16.30%) | $810,000 (518.32%) | $131,000 (285.29%) | $34,000 (0%) |
CNTA Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | 100.00% | - | - |
Profit Margin | - | -2204.70% | - | - |
EBITDA Margin | - | -2413.90% | - | - |
Return on Average Equity (ROAE) | -67.20% (-18.52%) | -56.70% (-5.59%) | -53.70% (32.88%) | -80.00% (37.11%) |
Return on Average Assets (ROAA) | -49.30% (-25.13%) | -39.40% (7.73%) | -42.70% (38.21%) | -69.10% (-1.92%) |
Return on Sales (ROS) | - | -2425.70% | - | - |
Return on Invested Capital (ROIC) | -79.40% (-22.15%) | -65.00% (76.54%) | -277.10% (81.96%) | -1536.10% (-399.06%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -8.13 (-60.37%) | -5.07 (-277.79%) | -1.34 (39.58%) | -2.22 |
Price to Sales Ratio (P/S) | - | 111.71 | - | - |
Price to Book Ratio (P/B) | 5.5 (67.17%) | 3.29 (277.29%) | 0.87 (-57.65%) | 2.06 |
Debt to Equity Ratio (D/E) | 0.44 (-16.95%) | 0.53 (63.04%) | 0.32 (14.59%) | 0.28 (-89.90%) |
Earnings Per Share (EPS) | -2.06 (-31.21%) | -1.57 (32.03%) | -2.31 (54.44%) | -5.07 |
Sales Per Share (SPS) | 0 (0%) | 0.07 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -1.24 (25.64%) | -1.67 (22.70%) | -2.16 (-19.94%) | -1.8 (-1351.61%) |
Book Value Per Share (BVPS) | 3.51 (42.83%) | 2.46 (-31.76%) | 3.6 (-44.97%) | 6.54 (18066.67%) |
Tangible Assets Book Value Per Share (TABVPS) | 5.04 (34.52%) | 3.75 (-21.25%) | 4.76 (-43.21%) | 8.38 (6059.56%) |
Enterprise Value Over EBIT (EV/EBIT) | -9 (-125.00%) | -4 (0%) | 0 (0%) | -1 |
Enterprise Value Over EBITDA (EV/EBITDA) | -8.55 (-105.43%) | -4.16 (-1145.98%) | 0.4 (134.88%) | -1.14 |
Asset Turnover | 0 (0%) | 0.02 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 9.25 (15.61%) | 8 (-29.94%) | 11.42 (-55.26%) | 25.52 (1870.66%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$142,089,000 (11.48%) | -$160,511,000 (20.41%) | -$201,683,000 (-49.07%) | -$135,295,000 (-1172.77%) |
Enterprise Value (EV) | $1,897,528,723 (175.54%) | $688,651,586 (925.77%) | -$83,394,634 (-119.24%) | $433,469,314 |
Earnings Before Tax (EBT) | -$232,913,000 (-32.23%) | -$176,141,000 (18.81%) | -$216,954,000 (43.05%) | -$380,957,000 (-3472.70%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$221,881,000 (-34.13%) | -$165,425,000 (21.06%) | -$209,546,000 (44.82%) | -$379,751,000 (-3484.25%) |
Invested Capital | $252,805,000 (-8.87%) | $277,419,000 (237.80%) | $82,125,000 (-4.08%) | $85,615,000 (5615.29%) |
Working Capital | $478,411,000 (73.52%) | $275,707,000 (-30.97%) | $399,409,000 (-33.89%) | $604,136,000 (23628.83%) |
Tangible Asset Value | $576,798,000 (60.11%) | $360,246,000 (-18.92%) | $444,307,000 (-29.43%) | $629,635,000 (5273.69%) |
Market Capitalization | $2,208,411,723 (184.18%) | $777,129,586 (165.01%) | $293,248,366 (-71.03%) | $1,012,284,314 |
Average Equity | $350,702,500 (31.66%) | $266,375,250 (-33.79%) | $402,320,000 (-15.52%) | $476,240,750 (5582.39%) |
Average Assets | $478,382,250 (24.71%) | $383,597,750 (-24.30%) | $506,725,250 (-8.12%) | $551,529,750 (3407.68%) |
Invested Capital Average | $280,776,750 (9.81%) | $255,683,000 (237.87%) | $75,674,000 (206.07%) | $24,724,500 (618.21%) |
Shares | 131,845,476 (35.05%) | 97,629,345 (3.21%) | 94,596,247 (5.22%) | 89,900,916 (4.63%) |
